Yao-Yun Fan
Research Subjects
Research Interests
Yao-Yun Fan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Denise M. O’hara
Biomedicine Design, Pfizer Worldwide Research & Development, Andover, MA 01810, USA
1 shared publication - Hendrik Neubert
Biomedicine Design, Worldwide Research & Development, Pfizer Inc, Andover, USA
1 shared publication - Mengmeng Wang
Biomedicine Design, Pfizer Worldwide Research & Development, Andover, MA 01810, USA
1 shared publication - Teresa Caiazzo
Biomedicine Design, Pfizer, Inc. 1 Burtt Rd, Building G, Andover, MA01810, USA
1 shared publication - Vahid Farrokhi
Biomedicine Design, Pfizer Worldwide Research & Development, Andover, MA 01810, USA
1 shared publication
Latest Publications
- Open Access
- 15 August 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (8) , 373
Human FcRn Tissue Expression Profile and Half-Life in PBMCs
System-wide quantitative characterization of human neonatal Fc receptor (FcRn) properties is critical for understanding and predicting human PK (pharmacokinetics) as well as the distribution of mAbs and Fc-fusion proteins using PBPK (physiologically-based pharmacokinetic) modeling. To this end, tissue-specific FcRn expression and half-life are important model inputs. Herein, human FcRn tissue expression was measured by peptide immunoaffinity chromatography coupled with high-resolution mass spectrometry. FcRn concentrations across 14 human tissues ranged from low to 230 pmol per gram of tissue. Furthermore, the FcRn half-life was determined to be 11.1 h from a human stable isotope labelled leucine pulse labeling experiment. The spatial and temporal quantitative human FcRn data now promise to enable a refined PBPK model with improved accuracy of human PK predictions for Fc-containing biotherapeutics.
- 15 August 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (8) , 373
Open AccessHuman FcRn Tissue Expression Profile and Half-Life in PBMCs
System-wide quantitative characterization of human neonatal Fc receptor (FcRn) properties is critical for understanding and predicting human PK (pharmacokinetics) as well as the distribution of mAbs and Fc-fusion proteins using PBPK (physiologically-based pharmacokinetic) modeling. To this end, tissue-specific FcRn expression and half-life are important model inputs. Herein, human FcRn tissue expression was measured by peptide immunoaffinity chromatography coupled with high-resolution mass spectrometry. FcRn concentrations across 14 human tissues ranged from low to 230 pmol per gram of tissue. Furthermore, the FcRn half-life was determined to be 11.1 h from a human stable isotope labelled leucine pulse labeling experiment. The spatial and temporal quantitative human FcRn data now promise to enable a refined PBPK model with improved accuracy of human PK predictions for Fc-containing biotherapeutics.